1303 related articles for article (PubMed ID: 26762955)
1. Genome Editing and Its Applications in Model Organisms.
Ma D; Liu F
Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
[TBL] [Abstract][Full Text] [Related]
2. Targeted genome editing tools for disease modeling and gene therapy.
Cai M; Yang Y
Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839
[TBL] [Abstract][Full Text] [Related]
3. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
4. Genetic correction using engineered nucleases for gene therapy applications.
Li HL; Nakano T; Hotta A
Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
[TBL] [Abstract][Full Text] [Related]
5. The CRISPR/Cas9 system for plant genome editing and beyond.
Bortesi L; Fischer R
Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
[TBL] [Abstract][Full Text] [Related]
6. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
7. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
8. [Genome-editing: focus on the off-target effects].
He X; Gu F
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
[TBL] [Abstract][Full Text] [Related]
9. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration.
Schmid B; Haass C
J Neurochem; 2013 Nov; 127(4):461-70. PubMed ID: 24117801
[TBL] [Abstract][Full Text] [Related]
10. Homology-Independent Integration of Plasmid DNA into the Zebrafish Genome.
Auer TO; Del Bene F
Methods Mol Biol; 2016; 1451():31-51. PubMed ID: 27464799
[TBL] [Abstract][Full Text] [Related]
11. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.
LaFountaine JS; Fathe K; Smyth HD
Int J Pharm; 2015 Oct; 494(1):180-94. PubMed ID: 26278489
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
[TBL] [Abstract][Full Text] [Related]
13. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
Ul Ain Q; Chung JY; Kim YH
J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
[TBL] [Abstract][Full Text] [Related]
14. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
15. Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases.
Hu JH; Davis KM; Liu DR
Cell Chem Biol; 2016 Jan; 23(1):57-73. PubMed ID: 26933736
[TBL] [Abstract][Full Text] [Related]
16. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
Liang Z; Zhang K; Chen K; Gao C
J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
[TBL] [Abstract][Full Text] [Related]
17. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in genome engineering techniques in the silkworm, Bombyx mori.
Daimon T; Kiuchi T; Takasu Y
Dev Growth Differ; 2014 Jan; 56(1):14-25. PubMed ID: 24175911
[TBL] [Abstract][Full Text] [Related]
19. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
Gaj T; Gersbach CA; Barbas CF
Trends Biotechnol; 2013 Jul; 31(7):397-405. PubMed ID: 23664777
[TBL] [Abstract][Full Text] [Related]
20. The CRISPR-Cas system for plant genome editing: advances and opportunities.
Kumar V; Jain M
J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
